Skip to content
2000
Volume 7, Issue 1
  • ISSN: 2210-6812
  • E-ISSN: 2210-6820

Abstract

The aim of the present study is to develop and formulate a nanoparticulate carrier for sustained and ocular delivery of Fluconazole and to study its in-vitro release characters. Chitosan nanoparticles of Fluconazole were formulated by spontaneous emulsification and cross-linking method. The mean particle size, drug loading capacity, invitro release profile and release kinetics were studied. The antifungal efficacies of nanospheres were compared with conventional eye drops by cup-plate method. The average particle size was found to be 152.85±13.7nm. The drug loading capacity of all drug loaded nanoparticles was found to be optimum (≤50%). The in-vitro release study revealed the zero order kinetics and Higuchi’s diffusion mechanism. The drug bound nanoparticles exhibited good in-vitro antifungal effect in comparison with conventional eye drops. The formulated nanoparticles were found to be a suitable carrier for sustained ocular delivery of Fluconazole in terms of optimum drug loading, sustained release characters and antifungal activity.

Loading

Article metrics loading...

/content/journals/nanoasi/10.2174/2210681206666160402003316
2017-04-01
2025-09-09
Loading full text...

Full text loading...

/content/journals/nanoasi/10.2174/2210681206666160402003316
Loading

  • Article Type:
    Research Article
Keyword(s): Chitosan; fluconazole; nanoparticles; ocular; sustained release
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test